TY - JOUR
T1 - Angiotensin II receptors subtypes mediate diverse gene expression profile in adult hypertrophic cardiomyocytes
AU - Zhou, Juan
AU - Xu, Xin
AU - Liu, Jin Jun
AU - Lin, Yuan Xi
AU - Gao, Guang Dao
PY - 2007/11
Y1 - 2007/11
N2 - 1. Although the systemic and cardiac renin-angiotensin systems are known to be activated in the setting of pressure overload, the actions and signalling mechanisms of angiotensin (Ang) II via AT1 and AT2 receptors in hypertrophic cardiomyocytes (CM) remain largely unclear. 2. Hypertrophic CM were prepared from rats with aortic banding for 8 weeks, cultured and then treated as follows: (i) 1 μmol/L AngII for 24 h; (ii) 10 μmol/L losartan (an AT1 receptor antagonist) for 1 h followed by 1 μmol/L AngII for 24 h; and (iii) 10 μmol/L PD123319 (an AT2 receptor antagonist) for 1 h followed by 1 μmol/L AngII for 24 h. Changes in the expression of genes following stimulation of AT1 and AT 2 receptors specific to G-protein-coupled receptor (GPCR) signalling pathways were tested using GEArray (Superarray, Bethesda, MD, USA). The effects of AngII, acting via AT1 and AT2 receptors, on the expression of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-6 were confirmed by reverse transcription-polymerase chain reaction and radioimmunoassay. 3. The genes regulated via stimulation of AT1 receptors were mainly restricted to the signalling pathways including cAMP/protein kinase (PK) A, Ca2+, PKC, protein tyrosine kinase, mitogen-activated protein kinases, phosphatidylinositol 3-kinase and nuclear factor-κB. In addition to these pathways related to activation of AT 1 receptors, four additional signalling pathways were found to be associated with stimulation of AT2 receptors, including phospholipase C, nitric oxide/cGMP, Rho and Janus kinase/signal transducer and activator of transcription. Blockade of AT2 receptors decreased the mRNA and protein expression of TNF-α and IL-1β, whereas blockade of AT 1 receptors had no such effect. 4. In conclusion, in hypertrophic CM, AngII leads to distinct signalling responses mediated by AT1 and AT2 receptors. Stimulation of AT2 receptors appears to have a greater influence on GPCR-signalling than stimulation of AT1 receptors. Angiotensin II enhances the synthesis and secretion of TNF-α and IL-1β in hypertrophic CM, which is mediated by AT2, but not AT1, receptors.
AB - 1. Although the systemic and cardiac renin-angiotensin systems are known to be activated in the setting of pressure overload, the actions and signalling mechanisms of angiotensin (Ang) II via AT1 and AT2 receptors in hypertrophic cardiomyocytes (CM) remain largely unclear. 2. Hypertrophic CM were prepared from rats with aortic banding for 8 weeks, cultured and then treated as follows: (i) 1 μmol/L AngII for 24 h; (ii) 10 μmol/L losartan (an AT1 receptor antagonist) for 1 h followed by 1 μmol/L AngII for 24 h; and (iii) 10 μmol/L PD123319 (an AT2 receptor antagonist) for 1 h followed by 1 μmol/L AngII for 24 h. Changes in the expression of genes following stimulation of AT1 and AT 2 receptors specific to G-protein-coupled receptor (GPCR) signalling pathways were tested using GEArray (Superarray, Bethesda, MD, USA). The effects of AngII, acting via AT1 and AT2 receptors, on the expression of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-6 were confirmed by reverse transcription-polymerase chain reaction and radioimmunoassay. 3. The genes regulated via stimulation of AT1 receptors were mainly restricted to the signalling pathways including cAMP/protein kinase (PK) A, Ca2+, PKC, protein tyrosine kinase, mitogen-activated protein kinases, phosphatidylinositol 3-kinase and nuclear factor-κB. In addition to these pathways related to activation of AT 1 receptors, four additional signalling pathways were found to be associated with stimulation of AT2 receptors, including phospholipase C, nitric oxide/cGMP, Rho and Janus kinase/signal transducer and activator of transcription. Blockade of AT2 receptors decreased the mRNA and protein expression of TNF-α and IL-1β, whereas blockade of AT 1 receptors had no such effect. 4. In conclusion, in hypertrophic CM, AngII leads to distinct signalling responses mediated by AT1 and AT2 receptors. Stimulation of AT2 receptors appears to have a greater influence on GPCR-signalling than stimulation of AT1 receptors. Angiotensin II enhances the synthesis and secretion of TNF-α and IL-1β in hypertrophic CM, which is mediated by AT2, but not AT1, receptors.
KW - Angiotensin II
KW - Angiotensin II receptors
KW - Cardiomyocytes
KW - Gene array
KW - Hypertrophy
KW - Interleukin-1β
KW - Tumour necrosis factor-α
UR - https://www.scopus.com/pages/publications/34548677049
U2 - 10.1111/j.1440-1681.2007.04694.x
DO - 10.1111/j.1440-1681.2007.04694.x
M3 - 文章
C2 - 17880376
AN - SCOPUS:34548677049
SN - 0305-1870
VL - 34
SP - 1191
EP - 1198
JO - Clinical and Experimental Pharmacology and Physiology
JF - Clinical and Experimental Pharmacology and Physiology
IS - 11
ER -